Evotec SE
EVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001412558
No open-market purchases or sales by Evotec SE insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $9.07M in total; no superinvestor holds it.
Other share classesEVOTF
13F holders, Q3 2024
Institutional positions in Evotec SE as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −3 vs. Q2 2024
- Shares held
- 7.98M
- +772.0K (+10.7%) vs. Q2 2024
- Total value
- $29.6M
- −$5.00M (−14.4%) vs. Q2 2024
- New holders
- 4
- 7 more added
- Sold out
- 7
- 7 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $9.07M |
| Q1 2026 | 46 | $20.3M |
| Q4 2025 | 44 | $30.4M |
| Q3 2025 | 37 | $35.9M |
| Q2 2025 | 37 | $40.5M |
| Q1 2025 | 25 | $30.4M |
| Q4 2024 | 26 | $36.9M |
| Q3 2024 | 24 | $29.6M |
| Q2 2024 | 28 | $35.0M |
| Q1 2024 | 20 | $38.7M |
| Q4 2023 | 28 | $66.5M |
| Q3 2023 | 24 | $12.0M |
| Q2 2023 | 20 | $15.4M |
| Q1 2023 | 19 | $14.5M |
| Q4 2022 | 22 | $21.1M |
| Q3 2022 | 22 | $43.5M |
| Q2 2022 | 21 | $57.3M |
| Q1 2022 | 22 | $83.3M |
| Q4 2021 | 20 | $157.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Evotec SE; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mubadala Investment Co PJSC | 4,597,701 | $16.8M | 0.09% | 00.0% | Unchanged |
| Wellington Management Group LLP | 2,634,434 | $9.62M | 0.00% | +602,858+29.7% | Added |
| Mediolanum International Funds Ltd | 140,383 | $984.7K | 0.01% | +140,383 | New |
| DCF Advisers, LLC | 217,055 | $792.3K | 0.41% | +102,102+88.8% | Added |
| Morgan Stanley | 122,454 | $447.0K | 0.00% | +644+0.5% | Added |
| Millennium Management LLC | 71,018 | $259.2K | 0.00% | −120,510−62.9% | Reduced |
| Goldman Sachs Group Inc | 57,141 | $208.6K | 0.00% | −7,715−11.9% | Reduced |
| BlackRock, Inc. | 51,163 | $186.7K | 0.00% | +51,163 | New |
| Clear Harbor Asset Management, LLC | 28,600 | $104.4K | 0.01% | +28,600 | New |
| Citadel Advisors LLC | 27,460 | $100.2K | 0.00% | +16,016+140.0% | Added |
| Mariner, LLC | 13,614 | $49.5K | 0.00% | +1,303+10.6% | Added |
| Quadrant Capital Group LLC | 6,200 | $22.6K | 0.00% | −8,016−56.4% | Reduced |
| Signaturefd, LLC | 5,158 | $18.8K | 0.00% | +674+15.0% | Added |
| Bank of America Corp | 3,539 | $12.9K | 0.00% | −2,429−40.7% | Reduced |
| Briaud Financial Planning, Inc | 2,160 | $7.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,030 | $3.76K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 734 | $2.68K | 0.00% | −964−56.8% | Reduced |
| Lindbrook Capital, LLC | 712 | $2.60K | 0.00% | −1,376−65.9% | Reduced |
| Advisor Group Holdings, Inc. | 466 | $1.70K | 0.00% | +134+40.4% | Added |
| Accent Capital Management, LLC | 412 | $1.50K | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 200 | $730 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 174 | $635 | 0.00% | −1,366−88.7% | Reduced |
| Bell Investment Advisors, Inc | 69 | $252 | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 42 | $153 | 0.00% | +42 | New |
| JustInvest LLC | 0 | $0 | 0.00% | −19,233−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −9,400−100.0% | Sold out |
| HHM Wealth Advisors, LLC | 0 | $0 | 0.00% | −450−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −109−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |